12:00 AM
 | 
Sep 24, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Alkermes completes debt financing

Alkermes plc (NASDAQ:ALKS), Dublin, Ireland
Business: Neurology, Endocrine/Metabolic, Autoimmune
Date completed: 9/19/12
Type: Debt financing
Raised: $375 million
Underwriters: Morgan Stanley; JPMorgan; Citigroup
Note: The debt comprises...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >